← brief for 2026-08-27 · Slowing decline

Jardiance

Drug label No results yet Not peer reviewed

Key takeaways

This is the official FDA label for Jardiance (empagliflozin), a daily pill that makes the kidneys pass extra sugar out in the urine. The label states it is approved to lower the risk of a lasting drop in kidney filtering rate (eGFR), of kidney failure, of death from heart causes, and of hospital stays, in adults with chronic kidney disease that is likely to get worse. A drug label is a regulatory document, not a study, so it carries no new results. The approval itself rests on earlier large trials.

Who did this work

Redpharm Drug

Source

Drug label · openFDA, renal drug labels · 2026-08-26
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=59ed43d9-b4e0-72a2-e063-6394a90a327d